BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Harris, Janelle L ^a   Richards, Renée S ^a,b   Chow, Clement W K ^a,b   Lee, Soon ^c   Kim, Misook ^b   Buck, Marion ^a,b   Teng, Linda ^b   Clarke, Raymond ^c   Gardiner, Robert A ^b   Lavin, Martin F ^a,b  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN BMCC1 1; RAB PROTEIN; TRANSCRIPTION FACTOR AP 2; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; BMCC1 GENE; CANCER CELL CULTURE; CELL LABELING; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOSOME; GENE; GENE SILENCING; GENETIC CODE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; MALE; MASS SPECTROMETRY; MELANOMA CELL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ADAPTOR PROTEIN COMPLEX 2; ANIMALS; CELL LINE, TUMOR; ENDOSOMES; GENE EXPRESSION; HUMANS; MALE; MICE; NEOPLASM PROTEINS; ORGAN SPECIFICITY; PROSTATIC NEOPLASMS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN TRANSPORT; TRANSPORT VESICLES;

EID: 84883609702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073880     Document Type: Article

References (35)

1. Dall'Era MA, Cooperberg MR, Chan JM, Davies BJ, Albertsen PC, et al. (2008) Active surveillance for early-stage prostate cancer: review of the current literature. Cancer 112: 1650-1659. doi:10.1002/cncr.23373. PubMed: 18306379.
2. Bussemakers MJ, van Bokhoven A, Verhaegh GW, Smit FP, Karthaus HF, et al. (1999) DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res 59: 5975-5979. PubMed: 10606244.
3. Hessels D, van Gils MP, van Hooij O, Jannink SA, Witjes JA, et al. (2010) Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer. Prostate 70: 10-16. doi:10.1002/pros.21032. PubMed: 19708043.
4. Salagierski M, Verhaegh GW, Jannink SA, Smit FP, Hessels D, et al. (2010) Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer. Prostate 70: 70-78. doi:10.1002/pros.21040. PubMed: 19760627.
5. Clarke RA, Zhao Z, Guo AY, Roper K, Teng L, et al. (2009) New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression. PLOS ONE 4: e4995. doi:10.1371/journal.pone.0004995. PubMed: 19319183.
6. Soh UJ, Low BC, (2008) BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. J Cell Sci 121: 1739-1749. doi:10.1242/jcs.021774. PubMed: 18445682.
7. Machida T, Fujita T, Ooo ML, Ohira M, Isogai E, et al. (2006) Increased expression of proapoptotic BMCC1, a novel gene with the BNIP2 and Cdc42GAP homology (BCH) domain, is associated with favorable prognosis in human neuroblastomas. Oncogene 25: 1931-1942. doi:10.1038/sj.onc.1209225. PubMed: 16288218.
8. Iwama E, Tsuchimoto D, Iyama T, Sakumi K, Nakagawara A, et al. (2011) Cancer-related PRUNE2 protein is associated with nucleotides and is highly expressed in mature nerve tissues. J Mol Neurosci 44: 103-114. doi:10.1007/s12031-010-9490-2. PubMed: 21234814.
9. Li S, Itoh M, Ohta K, Ueda M, Mizuno A, et al. (2011) The expression and localization of Prune2 mRNA in the central nervous system. Neurosci Lett 503: 208-214. doi:10.1016/j.neulet.2011.08.037. PubMed: 21893162.
10. Pan CQ, Low BC, (2012) Functional plasticity of the BNIP-2 and Cdc42GAP Homology (BCH) domain in cell signaling and cell dynamics. FEBS Lett 586: 2674-2691. doi:10.1016/j.febslet.2012.04.023. PubMed: 22710163.
11. Arama J, Boulay AC, Bosc C, Delphin C, Loew D, et al. (2012) Bmcc1s, a novel brain-isoform of Bmcc1, affects cell morphology by regulating MAP6/STOP functions. PLOS ONE 7: e35488. doi:10.1371/journal.pone.0035488. PubMed: 22523599.
12. Li S, Hayakawa-Yano Y, Itoh M, Ueda M, Ohta K, et al. (2012) Olfaxin as a novel Prune2 isoform predominantly expressed in olfactory system. Brain Res 1488: 1-13. doi:10.1016/j.brainres.2012.10.001. PubMed: 23059019.
13. Pavey S, Johansson P, Packer L, Taylor J, Stark M, et al. (2004) Microarray expression profiling in melanoma reveals a BRAF mutation signature. Oncogene 23: 4060-4067. doi:10.1038/sj.onc.1207563. PubMed: 15048078.
14. O'Rourke MG, Johnson MK, Lanagan CM, See JL, O'Connor LE, et al. (2007) Dendritic cell immunotherapy for stage IV melanoma. Melanoma Res 17: 316-322. doi:10.1097/CMR.0b013e3282c3a73b. PubMed: 17885587.
15. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45. doi:10.1093/nar/29.9.e45. PubMed: 11328886.
16. Harris JL, Jakob B, Taucher-Scholz G, Dianov GL, Becherel OJ, et al. (2009) Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Hum Mol Genet 18: 4102-4117. doi:10.1093/hmg/ddp359. PubMed: 19643912.
17. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS, (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20: 3551-3567. doi:10.1002/(SICI)1522-2683(19991201)20:18. PubMed: 10612281.
18. Aschenbrenner L, Lee T, Hasson T, (2003) Myo6 facilitates the translocation of endocytic vesicles from cell peripheries. Mol Biol Cell 14: 2728-2743. doi:10.1091/mbc.E02-11-0767. PubMed: 12857860.
19. Boucrot E, Saffarian S, Zhang R, Kirchhausen T, (2010) Roles of AP-2 in clathrin-mediated endocytosis. PLOS ONE 5: e10597. doi:10.1371/journal.pone.0010597. PubMed: 20485680.
20. Zhou YT, Soh UJ, Shang X, Guy GR, Low BC, (2002) The BNIP-2 and Cdc42GAP homology/Sec14p-like domain of BNIP-Salpha is a novel apoptosis-inducing sequence. J Biol Chem 277: 7483-7492. doi:10.1074/jbc.M109459200. PubMed: 11741952.
21. Rodemer C, Haucke V, (2008) Clathrin/AP-2-dependent endocytosis: a novel playground for the pharmacological toolbox? Handb Exp Pharmacol: pp. 105-122. PubMed: 18491050.
22. Doyon JB, Zeitler B, Cheng J, Cheng AT, Cherone JM, et al. (2011) Rapid and efficient clathrin-mediated endocytosis revealed in genome-edited mammalian cells. Nat Cell Biol 13: 331-337. doi:10.1038/ncb2175. PubMed: 21297641.
23. Roberts RL, Barbieri MA, Pryse KM, Chua M, Morisaki JH, et al. (1999) Endosome fusion in living cells overexpressing GFP-rab5. J Cell Sci 112(21):: 3667-3675. PubMed: 10523503.
24. Stenmark H, Parton RG, Steele-Mortimer O, Lütcke A, Gruenberg J, et al. (1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in endocytosis. EMBO J 13: 1287-1296. PubMed: 8137813.
25. Wilson JM, de Hoop M, Zorzi N, Toh BH, Dotti CG, et al. (2000) EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol Biol Cell 11: 2657-2671. doi:10.1091/mbc.11.8.2657. PubMed: 10930461.
26. Motley A, Bright NA, Seaman MN, Robinson MS, (2003) Clathrin-mediated endocytosis in AP-2-depleted cells. J Cell Biol 162: 909-918. doi:10.1083/jcb.200305145. PubMed: 12952941.
27. Hinrichsen L, Harborth J, Andrees L, Weber K, Ungewickell EJ, (2003) Effect of clathrin heavy chain- and alpha-adaptin-specific small inhibitory RNAs on endocytic accessory proteins and receptor trafficking in HeLa cells. J Biol Chem 278: 45160-45170. doi:10.1074/jbc.M307290200. PubMed: 12960147.
28. Narumiya S, Tanji M, Ishizaki T, (2009) Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 28: 65-76. doi:10.1007/s10555-008-9170-7. PubMed: 19160018.
29. Govek EE, Hatten ME, Van Aelst L, (2011) The role of Rho GTPase proteins in CNS neuronal migration. Dev Neurobiol 71: 528-553. doi:10.1002/dneu.20850. PubMed: 21557504.
30. Xing L, Yao X, Williams KR, Bassell GJ, (2012) Negative regulation of RhoA translation and signaling by hnRNP-Q1 affects cellular morphogenesis. Mol Biol Cell 23: 1500-1509. doi:10.1091/mbc.E11-10-0867. PubMed: 22357624.
31. Bosc C, Andrieux A, Job D, (2003) STOP proteins. Biochemistry 42: 12125-12132. doi:10.1021/bi0352163. PubMed: 14567673.
32. Boulay AC, Burbassi S, Lorenzo HK, Loew D, Ezan P, et al. (2013) Bmcc1s interacts with the phosphate-activated glutaminase in the brain. Biochimie 95: 799-807. doi:10.1016/j.biochi.2012.11.016. PubMed: 23246912.
33. Traub LM, (2009) Tickets to ride: selecting cargo for clathrin-regulated internalization. Nat Rev Mol Cell Biol 10: 583-596. doi:10.1038/nrm2751. PubMed: 19696796.
34. Huotari J, Helenius A, (2011) Endosome maturation. EMBO J 30: 3481-3500. doi:10.1038/emboj.2011.286. PubMed: 21878991.
35. Lau AW, Chou MM, (2008) The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. J Cell Sci 121: 4008-4017. doi:10.1242/jcs.033522. PubMed: 19033387.